Serial Number | 98161934 |
Word Mark | MEDILIGHT |
Filing Date | Friday, September 1, 2023 |
Status | 661 - RESPONSE AFTER NON-FINAL ACTION - ENTERED |
Status Date | Wednesday, October 23, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Goods and Services | Medical and surgical devices, apparatus, and instruments, namely, intense pulsed light (IPL) therapy and photofacial esthetic devices and instruments using light pulses for medical purposes; Medical devices for non-surgical esthetic skin treatments, namely, non-invasive medical devices for cosmetic skin treatments and hair removal |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Wednesday, September 27, 2023 |
Primary Code | 010 |
First Use Anywhere Date | Saturday, June 1, 2019 |
First Use In Commerce Date | Saturday, June 1, 2019 |
Party Name | Medicreations LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | Las Vegas, NV 89120 |
Event Date | Event Description |
Tuesday, September 5, 2023 | NEW APPLICATION ENTERED |
Wednesday, September 27, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Monday, April 22, 2024 | ASSIGNED TO EXAMINER |
Tuesday, April 23, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Tuesday, April 23, 2024 | NON-FINAL ACTION E-MAILED |
Tuesday, April 23, 2024 | NON-FINAL ACTION WRITTEN |
Thursday, July 18, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
Thursday, July 18, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
Wednesday, October 23, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
Wednesday, October 23, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Wednesday, October 23, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |